Abstract
We hypothesized that in Toxoplasma gondii infection, communication among immune cells promotes neuroinflammation through cytokine networks and induces pain sensitivity under conditions of neuropathic pain. The animal model of Toxoplasma infection was established by the intraperitoneal inoculation of 20–25 tissue cysts from Tehran strain of T. gondii to BALB/c mice. Amitriptyline (20 mg/kg, i.p., 1/day) administrated to animals for 7 days before behavioral tests. Pain behavioral tests including tail flick, hot plate, and formalin test were evaluated in all the groups. The mRNA levels of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 were examined by real-time PCR. Results revealed that T. gondii induce hyperalgesia in the infected mice, whereas amitriptyline showed a promising effect against the hyperalgesia induced by Toxoplasma infection. The mRNA levels of the aforementioned cytokines significantly (P < 0.05) increased in the infected mice compared to the uninfected ones. Obtained findings suggested that T. gondii infection could promote neuroinflammation through cytokine networks and induced hyperalgesia in BALB/c mice, whereas amitriptyline as an analgesic drug reverses them.
Similar content being viewed by others
References
Dubey, J.P. 2004. Toxoplasmosis—a waterborne zoonosis. Veterinary Parasitology 126: 57–72.
Mahmoudvand, H., E. Saedi Dezaki, S. Soleimani, M.R. Baneshi, F. Kheirandish, B. Ezatpour, and N. Zia-ali. 2015. Seroprevalence and risk factors of Toxoplasma gondii infection among healthy blood donors in southeast of Iran. Parasite Immunology 37(7): 362–367.
Montoya, J.G., and O. Liesenfeld. 2004. Toxoplasmosis. Lancet 363: 1965–1976.
Prandovszky, E., E. Gaskell, H. Martin, J.P. Dubey, J.P. Webster, and G.A. McConkey. 2011. The neurotropic parasite Toxoplasma gondii increase dopamine metabolism. PLoS ONE 6, e23866.
Gatkowska, J., M. Wieczorek, B. Dziadek, K. Dzitko, and H. Dlugonska. 2013. Sex-dependent neurotransmitter level changes in brains of Toxoplasma gondii infected mice. Experimental Parasitology 133: 1–7.
Gureje, O., M. von Korff, G.E. Simon, and R. Gater. 1998. Persistent pain and well-being: a World Health Organization study in primary care. Journal American Medical Association 280(2): 147–151.
Raj, P.P. 2007. Taxonomy and classification of pain. In: Niv D, Kreitler S, Diego B, Lamberto A. The handbook of chronic pain. Nova Biomedical Books.
Calvo, M., J.M. Dawes, and D.L. Bennett. 2012. The role of the immune system in the generation of neuropathic pain. The Lancet Neurology 11: 629–642.
Marchand, F., M. Perretti, and S.B. McMahon. 2005. Role of the immune system in chronic pain. Nature Reviews Neuroscience 6: 521–532.
Scholz, J., and C.J. Woolf. 2007. The neuropathic pain triad: neurons, immune cells and glia. Nature Neuroscience 10: 1361–1368.
Thacker, M.A., A.K. Clark, F. Marchand, and S.B. McMahon. 2007. Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesthesia & Analgesia 105: 838–847.
Liesenfeld, O., I. Parvanova, J. Zerrahn, S.J. Han, F. Heinrich, M. Munoz, et al. 2011. The IFN- gammainducible GTPase, Irga6, protects mice against Toxoplasma gondii but not against Plasmodium berghei and some other intracellular pathogens. PLoS ONE 6, e20568.
Munoz, M., O. Liesenfeld, and M.M. Heimesaat. 2011. Immunology of Toxoplasma gondii. Immunological Reviews 240: 269–285.
Dunn, A.J. 2006. Effects of cytokines and infections on brain neurochemistry. Clinical Neuroscience Research 6: 52–68.
McCusker, R.H., and K.W. Kelley. 2013. Immune-neural connections: how the immune system’s response to infectious agents influences behavior. The Journal of Experimental Biology 216: 84–98.
Saito, K., S.P. Markey, and M.P. Heyes. 1991. Chronic effects of gamma-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57BL6 mice. Brain Research 546: 151–154.
Finnerup, N.B., M. Otto, H.J. McQuay, T.S. Jensen, and S.H. Sindrup. 2005. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118(3): 289–305.
Micó, J.A., J. Gibert-Rahola, J. Casas, O. Rojas, M.I. Serrano, and J.S. Serrano. 1997. Implication of beta 1- and beta 2-adrenergic receptors in the antinociceptive effect of tricyclic antidepressants. European Neuropsychopharmacology 7(2): 139–145.
McCleane, G. 2000. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. British Journal of Clinical Pharmacology 49(6): 574–579.
Verdu, B., I. Decosterd, T. Buclin, F. Stiefel, and A. Berney. 2008. Antidepressants for the treatment of chronic pain. Drugs 68(18): 2611–2632.
Saraei, M., Y. Ghaderi, T. Mosavi, M. Shahnazi, H. Keshavarz, and S. Shojaee. 2014. Brain cystogenesiscapacity of Toxoplasma gondii, avirulent Tehran strain in mice. Asian Pacific Journal Tropical Disease 4(2): 739–742.
Hosseinzadeh, H., M.H. Haddadkhodaparast, and A.R. Arash. 2003. Antinociceptive, antiinflammatory and acute toxicity effects of Salvia leriifolia Benth seed extractin mice and rats. Phytotherapy Research 17(4): 422–425.
Esmaeili-Mahani, S., M. Rezaeezadeh-Roukerd, K. Esmaeilpour, M. Abbasnejad, B. Rasoulian, V. Sheibani, A. Kaeidi, and Z. Hajializadeh. 2010. Olive (Olea europaea L.) leaf extract elicits antinociceptive activity, potentiates morphine analgesia and suppresses morphine hyperalgesia in rats.Journal of. Ethnopharmacology 132(1): 200–205.
Ha, T.Y., K.A. Chang, J.A. Kim, H.S. Kim, S. Kim, et al. 2010. S100a9 knockdown decreases the memory impairment and the neuropathology in Tg2576, AD animal model. PLoS ONE 5, e8840.
Fekadu, A., T. Shibre, and A.J. Cleare. 2010. Toxoplasmosis as a cause for behavior disorders—overview ofevidence and mechanisms. Folia Parasitolgica (Praha) 57: 105–113.
Miman, O., E.A. Mutlu, O. Ozcan, M. Atambay, R. Karlidag, and S. Unal. 2010. Is there any role of Toxoplasma gondii in the etiology of obsessive–compulsive disorder? Psychiatry Research 177: 263–265.
Torrey, E.F., J.J. Bartko, and R.H. Yolken. 2012. Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophrenia Bulletin 38: 642–647.
Lambert, H., P.P. Vutova, W.C. Adams, K. Lore, and A. Barragan. 2009. The Toxoplasma gondii-shuttling function of dendritic cells in link to the parasite genotype. Infection and Immunity 77: 1679–1688.
Novotná, M., J. Hanusova, J. Klose, M. Preiss, J. Havlicek, K. Roubalová, and J. Flegr. 2015. Probable neuroimmunological link between Toxoplasma and cytomegalovirus infections and personality changes in the human host. BMC Infectiuos Diseases 5, e54.
Webster, J.P. 2007. The effect of Toxoplasma gondii on animal behavior: playing cat and mouse. Schizophrenia Bulletin 33: 752–756.
Daniels, B.P., S.R. Sestito, and S.T. Rouse. 2015. An expanded task battery in the Morris water maze reveals effects of Toxoplasma gondii infection on learning and memory in rats. Parasitology International 64(1): 5–12.
Möhle, L., A. Parlog, J. Pahnke, and I.R. Dunay. 2014. Spinal cord pathology in chronic experimental Toxoplasma gondii infection. European Journal of Microbiology and Immunology (Bp) 4(1): 65–75.
Nickel, F.T., F. Seifert, S. Lanz, and C. Maihöfner. 2012. Mechanisms of neuropathic pain. European Neuropsychopharmacology 22(2): 81–91.
Henriquez, S.A., R. Brett, J. Alexander, J. Pratt, and C.W. Roberts. 2009. Neuropsychiatric disease and Toxoplasma gondii infection. Neuroimmunomodulation 16: 122–133.
Austin, P.J., and G. Moalem-Taylor. 2010. The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. Journal of Neuroimmunology 229(1–2): 26–50.
Clark, A.K., E.A. Old, and M. Malcangio. 2013. Neuropathic pain and cytokines: current perspectives. Journal of Pain Research 6: 803–814.
Tsuda, M., T. Masuda, H. Tozaki-Saitoh, and K. Inoue. 2013. Microglial regulation of neuropathic pain. Journal of Pharmaceutical Sciences 121: 89–94.
Mika, J., A.M. Jurga, J. Starnowska, M. Wasylewski, E. Rojewska, W. Makuch, K. Kwiatkowski, N. Malek, and B. Przewlocka. 2015. Effects of chronic doxepin and amitriptyline administration in naïve mice and in neuropathic pain mice model. Neuroscience 21(294): 38–50.
Saarto, T., and P.J. Wiffen. 2007. Antidepressants for neuropathic pain. Cochrane Database of Systematic Reviews 17(4), CD005454.
Goldstein, D.J., Y. Lu, M.J. Detke, T.C. Lee, and S. Iyengar. 2005. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 116(1–2): 109–118.
Sawynok, J., M. Esser, and A.R. Reid. 2001. Antidepressants as analgesics: an overview of central and peripheral mechanisms of action. Journal of Psychiatry & Neuroscience 26(1): 21–29.
Stahl, S.M. 1998. Basic psychopharmacology of antidepressants, part 1: antidepressants have seven distinct mechanisms of action. Journal of Clinical Psychiatry 59(4): 5–14.
Acknowledgments
We would like to thank Dr. Saedi Dezaki and Mr. Ali Reza Keyhani for performance of the molecular analysis.
Compliance with Ethical Standards
This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Committee on the Ethics of Animal Experiments of the Kerman University of Medical Science (permit number: 1508). Moreover, all efforts were made to minimize suffering.
Conflict of Interest
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mahmoudvand, H., Ziaali, N., Ghazvini, H. et al. Toxoplasma gondii Infection Promotes Neuroinflammation Through Cytokine Networks and Induced Hyperalgesia in BALB/c Mice. Inflammation 39, 405–412 (2016). https://doi.org/10.1007/s10753-015-0262-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-015-0262-6